GB1538717A - Cyclopentanol lactones - Google Patents
Cyclopentanol lactonesInfo
- Publication number
- GB1538717A GB1538717A GB11602/77A GB1160277A GB1538717A GB 1538717 A GB1538717 A GB 1538717A GB 11602/77 A GB11602/77 A GB 11602/77A GB 1160277 A GB1160277 A GB 1160277A GB 1538717 A GB1538717 A GB 1538717A
- Authority
- GB
- United Kingdom
- Prior art keywords
- group
- those
- compounds
- formula
- image
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
- -1 Cyclopentanol lactones Chemical class 0.000 title 1
- 150000001875 compounds Chemical class 0.000 abstract 3
- 206010020772 Hypertension Diseases 0.000 abstract 2
- 125000000304 alkynyl group Chemical group 0.000 abstract 1
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 abstract 1
- 150000001735 carboxylic acids Chemical class 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- 208000035475 disorder Diseases 0.000 abstract 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 abstract 1
- 230000001077 hypotensive effect Effects 0.000 abstract 1
- 150000002576 ketones Chemical class 0.000 abstract 1
- 125000003198 secondary alcohol group Chemical group 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D213/81—Amides; Imides
- C07D213/82—Amides; Imides in position 3
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D305/00—Heterocyclic compounds containing four-membered rings having one oxygen atom as the only ring hetero atoms
- C07D305/14—Heterocyclic compounds containing four-membered rings having one oxygen atom as the only ring hetero atoms condensed with carbocyclic rings or ring systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D309/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
- C07D309/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
- C07D309/08—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D309/10—Oxygen atoms
- C07D309/12—Oxygen atoms only hydrogen atoms and one oxygen atom directly attached to ring carbon atoms, e.g. tetrahydropyranyl ethers
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
- C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D311/94—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems condensed with rings other than six-membered or with ring systems containing such rings
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Furan Compounds (AREA)
- Epoxy Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR7608004A FR2344285A1 (fr) | 1976-03-19 | 1976-03-19 | Nouvelles lactones derivees du cyclopentanol, leur procede de preparation et leur application comme medicaments |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| GB1538717A true GB1538717A (en) | 1979-01-24 |
Family
ID=9170682
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| GB11602/77A Expired GB1538717A (en) | 1976-03-19 | 1977-03-18 | Cyclopentanol lactones |
Country Status (20)
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1142886A1 (en) * | 2000-04-07 | 2001-10-10 | Aventis Pharma Deutschland GmbH | Percyquinnin, a process for its production and its use as a pharmaceutical |
| CN100417650C (zh) * | 2006-08-17 | 2008-09-10 | 中国科学院昆明植物研究所 | 韧革菌素及其制备方法和在药物上的应用 |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2439779A2 (fr) * | 1976-03-19 | 1980-05-23 | Roussel Uclaf | Nouvelles lactones derivees du cyclopentanol, leur procede de preparation et leur application comme medicaments |
| FR2443466A1 (fr) * | 1978-12-05 | 1980-07-04 | Roussel Uclaf | Nouvelles b-lactones derivees de l'acide 2-hydroxy cyclopentane carboxylique, leur procede de preparation et leur application comme medicaments |
| DE3722133A1 (de) * | 1987-07-04 | 1989-01-12 | Bayer Ag | Azolyl-tetrahydropyran-derivate |
| KR100581647B1 (ko) * | 2001-07-17 | 2006-05-22 | 파마시아 앤드 업존 캄파니 엘엘씨 | 라타노프로스트 제조를 위한 방법 및 중간체 |
-
1976
- 1976-03-19 FR FR7608004A patent/FR2344285A1/fr active Granted
-
1977
- 1977-03-15 SE SE7702908A patent/SE436877B/sv not_active IP Right Cessation
- 1977-03-17 HU HU77RO921A patent/HU178332B/hu unknown
- 1977-03-18 DE DE19772711950 patent/DE2711950A1/de not_active Ceased
- 1977-03-18 CH CH343677A patent/CH620688A5/fr not_active IP Right Cessation
- 1977-03-18 ZA ZA00771654A patent/ZA771654B/xx unknown
- 1977-03-18 LU LU76976A patent/LU76976A1/xx unknown
- 1977-03-18 ES ES456999A patent/ES456999A1/es not_active Expired
- 1977-03-18 BE BE175906A patent/BE852624A/xx not_active IP Right Cessation
- 1977-03-18 CA CA274,256A patent/CA1094569A/fr not_active Expired
- 1977-03-18 IL IL51690A patent/IL51690A/xx unknown
- 1977-03-18 SU SU772480801A patent/SU749364A3/ru active
- 1977-03-18 GB GB11602/77A patent/GB1538717A/en not_active Expired
- 1977-03-18 DK DK119377A patent/DK119377A/da not_active Application Discontinuation
- 1977-03-19 PT PT66326A patent/PT66326B/pt unknown
- 1977-03-19 JP JP2981777A patent/JPS52113956A/ja active Granted
- 1977-03-21 IE IE601/77A patent/IE45124B1/en unknown
- 1977-03-21 NL NL7703056A patent/NL7703056A/xx not_active Application Discontinuation
- 1977-03-21 AT AT195077A patent/AT357275B/de active
- 1977-03-21 AU AU23466/77A patent/AU506760B2/en not_active Expired
-
1978
- 1978-06-08 SU SU782623757A patent/SU745366A3/ru active
Cited By (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1142886A1 (en) * | 2000-04-07 | 2001-10-10 | Aventis Pharma Deutschland GmbH | Percyquinnin, a process for its production and its use as a pharmaceutical |
| WO2001077094A1 (en) * | 2000-04-07 | 2001-10-18 | Aventis Pharma Deutschland Gmbh | Percyquinnin, a process for its production and its use as a pharmaceutical |
| US6596518B2 (en) | 2000-04-07 | 2003-07-22 | Aventis Pharma Deutschland Gmbh | Percyquinnin, a process for its production and its use as a pharmaceutical |
| RU2266290C2 (ru) * | 2000-04-07 | 2005-12-20 | Авентис Фарма Дойчланд Гмбх | Перцихиннин, способ его получения и его применение в качестве фармацевтического средства |
| CN100417650C (zh) * | 2006-08-17 | 2008-09-10 | 中国科学院昆明植物研究所 | 韧革菌素及其制备方法和在药物上的应用 |
Also Published As
| Publication number | Publication date |
|---|---|
| IL51690A0 (en) | 1977-05-31 |
| SU745366A3 (ru) | 1980-06-30 |
| BE852624A (fr) | 1977-09-19 |
| NL7703056A (nl) | 1977-09-21 |
| LU76976A1 (enrdf_load_html_response) | 1977-10-03 |
| JPS52113956A (en) | 1977-09-24 |
| PT66326B (pt) | 1979-01-18 |
| HU178332B (en) | 1982-04-28 |
| AU2346677A (en) | 1978-09-28 |
| AT357275B (de) | 1980-06-25 |
| ZA771654B (en) | 1978-04-26 |
| FR2344285A1 (fr) | 1977-10-14 |
| JPS62146B2 (enrdf_load_html_response) | 1987-01-06 |
| ES456999A1 (es) | 1978-01-16 |
| AU506760B2 (en) | 1980-01-24 |
| PT66326A (fr) | 1977-04-01 |
| CA1094569A (fr) | 1981-01-27 |
| SE7702908L (sv) | 1977-09-20 |
| DE2711950A1 (de) | 1977-09-29 |
| ATA195077A (de) | 1979-11-15 |
| SE436877B (sv) | 1985-01-28 |
| IE45124B1 (en) | 1982-06-30 |
| FR2344285B1 (enrdf_load_html_response) | 1979-02-02 |
| SU749364A3 (ru) | 1980-07-15 |
| DK119377A (da) | 1977-09-20 |
| IL51690A (en) | 1982-02-28 |
| CH620688A5 (en) | 1980-12-15 |
| IE45124L (en) | 1977-09-19 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP0014720A4 (en) | TENSIOMETER. | |
| GB1538717A (en) | Cyclopentanol lactones | |
| AU8287487A (en) | Process for the preparation of 1,1,2,2- tetrahydroperfluoroalkanols and their esters | |
| ES473534A1 (es) | Procedimiento para la preparacion de analogos de prostaci- clina | |
| GB1457264A (en) | Pregnane acid derivatives | |
| Kakisawa et al. | The stereochemistry of the grayanotoxins | |
| JPS5762295A (en) | Manufacture of 17alpha-hydroxy- and 17a alpha-hydroxy-d-homo-etiocarboxylic acid | |
| GB1427910A (en) | Method of preparing a methacrylic acid ester | |
| CH609024A5 (en) | Process for the preparation of new sulphur-containing diaryl and oxygen-containing diaryl compounds | |
| AU8284387A (en) | Synthesis of 1,1,2,2-tetrahydroperfluoroalkanols and their esters | |
| SE7510466L (sv) | Prostansyraderivat | |
| GB1307227A (en) | Pharmaceutical compositions comprising dicarboxylic acids and their derivatives | |
| GB1330520A (en) | Polymers of thio-substituted compounds | |
| GB1380555A (en) | Process for the preparation of 2,3,5-trimethylhydroquinone | |
| JPS51122056A (en) | Steroid carboxylic acid and derivatives thereof | |
| CH609668A5 (en) | Process for the preparation of acetic acid derivatives | |
| ES433554A1 (es) | Un procedimiento para la produccion de nuevos compuestos deacido xantona-2-carboxilicos 5-7-disustituidos. | |
| ES434548A1 (es) | Procedimiento para preparar esteres de diglicidilo de aci- dos dicarboxilicos cicloalifaticos. | |
| JPS53130618A (en) | Preparation of 2,4,6,8 tetramethyldecanoic acid or its ester | |
| JPS5432473A (en) | Antibiotics pseudomonic acid derivative and its preparation | |
| JPS52102203A (en) | Manufacture of esters | |
| JPS5396095A (en) | Preparation of polyester | |
| JPS53137926A (en) | Treatment of residue of distillation of phthalic anhydride | |
| DE3461926D1 (en) | Cycloaliphatic aminosulphonic-acid derivatives, process for their production and pharmaceutical preparations for combating heart and vascular diseases | |
| JPS5283427A (en) | Preparation of alpha-substituted propionic acids and their salts |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PS | Patent sealed [section 19, patents act 1949] | ||
| PCNP | Patent ceased through non-payment of renewal fee |